Pharmaceutical Filtration Market

Pharmaceutical Filtration Market Size (2023 to 2028)

The global pharmaceutical filtration market size is forecasted to grow at a CAGR of 9% between 2023 to 2028 and be worth USD 29.81 billion by 2028 from USD 19.38 billion in 2023.

Pharmaceutical Filtration Market Share Insights:

• Based on product, the membrane filter segment dominated the market in 2022, and the single-use systems segment is expected to grow aggressively in the coming years.
• Based on technique, the microfiltration segment captured the leading share of the global pharmaceutical filtration market in 2022.
• Based on application, the final product processing segment had the leading share of the global market in 2022.
• Based on the scale of operation, the manufacturing segment led the market in 2022.
• The APAC region accounted for the dominating share of the global market in 2022.

MARKET DRIVERS:

Strict cleanliness requirements in pharmaceutical manufacturing facilities propel the pharmaceutical filtration market growth. It is essential to maintain strict cleanliness standards to ensure the purity and quality of the product among the companies operating in the pharmaceutical industry. The filtration systems are vital in removing contaminants and impurities from liquids and gases during manufacturing. Depth filters, membrane filters, and adsorption filters are some types of filtration systems designed to remove contaminants such as bacteria, particles and gases. The growing demand for high-quality pharmaceutical products and the requirement to meet regulatory standards are anticipated to result in the growing usage of pharmaceutical filtration and boost market growth.

In addition, an increase in the production of various large molecules and a rise in the manufacture of vaccines due to the incidence of various diseases such as chikungunya, dengue, and malaria propel the pharmaceutical filtration market growth. Furthermore, an increase in R&D funding, growing adoption of technological advancements such as infiltration techniques, and a rise in the generic drugs market also promote the growth of the pharmaceutical filtration market.

The growing biopharmaceutical industry and untapped market potential from emerging economies is expected to offer tremendous growth opportunities to the global pharmaceutical filtration market. Developing countries such as India, China, Russia, and Brazil provide immense growth opportunities for the participants in the pharmaceutical filtration market. Furthermore, growth in the healthcare sector and the low manufacturing cost are expected to offer more than enough market players chances. In addition, increasing product sales in a particular market and demand for pharmaceutical filtration in developing countries offer lucrative opportunities to the global market players.

MARKET RESTRAINTS:

Stringent regulatory requirements, high costs of filtration systems and limited product differentiation majorly hamper the growth of the pharmaceutical filtration market. Lack of skilled workforce, product quality and safety concerns and complex manufacturing processes further hinder the market growth. Resistance to adopt new technologies, stringent validation requirements and growing raw material costs impede the market growth.

Impact of COVID-19 on the global pharmaceutical filtration market:

The novel COVID-19 caused by the SARS-CoV-2 agent affects millions of people, the business sector, and healthcare. The governments have imposed a severe lockdown from March to May. Many pharmaceutical and biotechnology companies have temporarily shut their doors due to a lack of workforce to avoid widespread disease. The pandemic has created a positive effect on the pharmaceutical filtration market. Filtration technologies play a vital role in response to the impact of COVID-19. Most pharmaceutical filtration manufacturers worldwide interrupted their activities during the COVID-19 pandemic lockdown. The demand for these filtration systems has risen over the pandemic time. The increase is due to continuous research and development of vaccines to recover from virus-infected patients. The pharmaceutical filtration market demand is due to the threat of COVID-19 transmission via air in indoor spaces. The Nanotech filter coating air filters to capture airborne or droplets of the virus. The demand for this market is accumulating to develop purity.

REPORT COVERAGE:

This research report on the global pharmaceutical filtration market has been segmented and sub-segmented based on the product, technique, application, scale of operation, and region.

Pharmaceutical Filtration Market – By Product:

• Membrane Filters
  • MCE Membrane Filters
  • Coated Cellulose Acetate Membrane Filters
  • Nylon Membrane Filters
  • PTFE Membrane Filters
  • PVDF Membrane Filters
  • Other Membrane Filters
• Prefilters And Depth Media Filters
  • Glass Fiber Filters
  • PTFE Fiber Filters
• Single-Use Systems
• Cartridge& Capsule Filters
• Filter Holders
• Filtration Accessories
• Other Products

Based on the product, the membrane filters segment accounted for the largest share of the pharmaceutical filtration market in 2022 and is anticipated to project a healthy CAGR in the coming years. The membrane filters are effortless to install among large and small systems, and products are readily available in different polymers. These factors are pushing the market forward. The market is driving further with the rapid development of drugs and biological industries, the burgeoning frequency of viral and chronic diseases, and the swelling demand for advanced medicines and vaccines to escalate the pharmaceutical filtration market growth. 

The single-use systems segment is predicted to grow at an impressive CAGR pace during the assessment period. This is because the systems provide benefits like limiting the threat of contamination, reducing the operation time, and providing comfort, propelling the market's demand. 

Pharmaceutical Filtration Market – By Technique:

• Microfiltration
• Ultrafiltration
• Nanofiltration
• Other techniques

Based on the technique, the microfiltration segment is predicted to account for the leading share of the global pharmaceutical filtration market during the forecast period. The effectiveness of microfiltration in separating large particles, high flow rates and low energy requirements primarily drive the growth of the microfiltration segment. The growing demand for sterile filtration in pharmaceutical manufacturing and the increasing need for effective clarification processes contribute to the growth of the microfiltration segment in the pharmaceutical filtration market.

The nanofiltration segment is estimated to hold a substantial share of the global market during the forecast period. The ability of nanofiltration to provide precise separation of desired molecules, such as the removal of endotoxins and impurities from pharmaceutical products primarily drives the growth of the nanofiltration segment in the pharmaceutical filtration market. The rising emphasis on purification processes, stringent quality requirements, and the demand for high-purity pharmaceuticals support the growth of the nanofiltration segment in the pharmaceutical filtration market.

The ultrafiltration segment is forecasted to witness a healthy CAGR in the coming years. The growing increasing adoption of biopharmaceuticals that require efficient separation and concentration processes and the advantages of ultrafiltration, such as high selectivity, scalability, and minimal damage to biomolecules boost the growth rate of the ultrafiltration segment.

Pharmaceutical Filtration Market – By Application:

• Final Product Processing
  • API Filtration
  • Sterile Filtration
  • Protein Purification
  • Vaccine And Antibody Processing
  • Formulation And Filling Solution Filtration
  • Viral Clearance
• Raw Material Filtration
  • Media And Buffer Filtration
  • Prefiltration And Bioburden Testing
• Cell Separation
• Water Purification
• Air Purification

The final product processing segment is expected to register the highest CAGR during the forecast period based on application. The growing adoption of new filters for final product processing and the intensifying adoption of biologics and other protein therapeutic proteins lead to protein purification processes fuelling the segment's growth. 

The cell separation segment is anticipated to showcase a healthy CAGR during the forecast period. Cell separation is essential for diverse applications to produce a monoclonal antibody. The easy availability of advanced products with well-developed infrastructure and the existence of leading healthcare companies.

Pharmaceutical Filtration Market – By the Scale of Operation:

• Manufacturing Scale
• Pilot-Scale
• R&D Sector

Based on the operation scale, the manufacturing scale segment is expected to grow at a promising CAGR during the forecast period owing to the rising demand for pharmaceutical products, increasing need for efficient and reliable filtration processes in large-scale production, and emphasis on ensuring product quality and safety. The implementation of advanced filtration systems and technologies to meet regulatory requirements, improve productivity, and reduce operational costs also contribute to the growth of the manufacturing scale segment in the pharmaceutical filtration market.

Pharmaceutical Filtration Market – By Region:

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East and Africa

Geographically, the pharmaceutical filtration market in North America was the largest regional market worldwide in 2022 and is anticipated to hold the dominating position in the worldwide market throughout the forecast period. The presence of a well-established pharmaceutical industry and significant investments in research and development across North America primarily drive the pharmaceutical filtration market growth in North America. The presence of major pharmaceutical companies and contract manufacturing organizations contributes to the demand for filtration technologies and drives the North American market growth. Stringent regulatory standards for pharmaceutical manufacturing, such as Good Manufacturing Practices (GMP), drive the adoption of advanced filtration solutions to ensure product safety and compliance and support regional market growth. The rising prevalence of chronic diseases, a growing aging population and increasing need for innovative drugs further favor the market growth in North America. The U.S. market is anticipated to hold a major share of the North American market during the forecast period, followed by Canada. The growing adoption of technologically well-developed filtration technologies and the presence of many pharmaceutical manufacturers primarily propel the U.S. market growth. The Canadian market is forecasted to register a healthy CAGR during the forecast period.

However, the pharmaceutical filtration market in the Asia Pacific is expected to grow at the highest CAGR during the forecast period. Factors such as the growing population, increasing disposable income and the growing number of improvements in the healthcare infrastructure across the Asia-Pacific region contribute to the APAC market growth. The rapid expansion of the pharmaceutical industry with countries like China and India emerging as major manufacturing hubs and the presence of a large patient pool, growing pharmaceutical exports and favorable government initiatives to enhance healthcare facilities drive the demand for pharmaceutical filtration technologies in the Asia-Pacific region and fuel the regional market growth. The growing investments in research and development and rapid adoption of advanced healthcare technologies further propel the APAC market growth. China held the major share of the APAC market in 2022, followed by India and Japan.

The European region is one of the potential markets for pharmaceutical filtration and is considered home to some of the leading pharmaceutical manufacturers worldwide. The growth of the pharmaceutical filtration market in Europe is driven by the increasing demand for biopharmaceuticals, the presence of many generic drug manufacturers, and the implementation of stringent regulatory standards related to the quality and purity of pharmaceutical products. As a result, countries such as Germany, France, and the UK are expected to control a significant share of the European market in the coming years. However, Italy, Spain, and the Netherlands will showcase a healthy CAGR during the forecast period.

The Latin American pharmaceutical filtration market is anticipated to register a healthy CAGR during the forecast period due to factors such as favorable government policies, increasing investments in the pharmaceutical sector, and the adoption of advanced filtration solutions to ensure product safety and quality.

The pharmaceutical filtration market in MEA is expected to occupy a moderate share of the global market in the coming years. Factors such as the growing investment in healthcare infrastructure, expanding pharmaceutical manufacturing capabilities and rising awareness of the importance of quality pharmaceutical products boost the MEA market growth.

KEY MARKET PARTICIPANTS:

Some of the most promising companies that are dominating the global pharmaceutical filtration market profiled in this report are Merck KGaA, Pall Corporation, GE Healthcare, 3M Company, Parker Hannifin Corporation, Sartorius Stedim Biotech S.A., Eaton Corporation PLC, Graver Technologies, LLC, Amazon Filters Ltd., and Meissner Filtration Products, Inc.

RECENT MARKET DEVELOPMENTS:

• In February 2020, the Industrial Gas Filtration and Generation Division of Parker Hannifin Corporation, a leader in motion and control technologies, announced the launch of Protura SB Nano Pleated Filters, a dust collection filter used in a variety of demanding applications. 
• In September 2019, Parker Hannifin Corporation, the global leader in motion and control technologies, completed the Exotic Metals Forming acquisition. Company. 
• In July 2019, ID Genomics, SPC announced the completion of its first pre-submission meeting with the FDA for the CloNet coli Assay for Urinary Tract Infections. (UTIs).  
• In December 2019, Eaton Corporation plc, a power management company, announced that it had completed the acquisition of the Souriau-Sunbank Connection Technologies business of TransDigm. Group. 
• In January 2018, Meissner Filtration Products announced that it had acquired PDC Aseptic Filling Systems, an advanced aseptic filling system, and sealers to the pharmaceutical industry.